This solution by LabCorp (LH) takes the idea from Covance's COVID-19 Operational Recovery Team to better understand the necessities.

LabCorp Introduces Xcellerate® COVID-19 Clinical Study Solution Advanced Analytics and Visualizations Empower Study Teams to Respond to Dynamic Environment, Manage Risk, Resume Studies and ...

Covance Xcellerate® Wins Best Technological Development in Clinical Trials (Clinical Sponsor-Focused) at 14 th Annual Scrip Awards. December 07, 2018 08:45 AM Eastern Standard Time.

W. CONSHOHOCKEN, Pa., June 28, 2022 /PRNewswire/ -- Today, global standards organization ASTM International launched ASTM Xcellerate™, an emerging technology program focused on strengthening the ...

Through Xcellerate Monitoring, Covance has transformed clinical trial risks into measurable returns for clinical research stakeholders with initial improvements in data quality, patient safety and ...

Laboratory Corporation of America Holdings or LabCorp LH is leaving no stone unturned to develop COVID-19-related support. Following last week‘s launch of a new antibody test, the company’s ...

LabCorp introduces Xcellerate COVID-19 clinical study solution: Burlington, North Carolina Wednesday, July 1, 2020, 14:00 Hrs [IST] LabCorp, a leading global life sciences company that is deeply ...

category Rwanda's Marburg cases decline but mpox spreading in Africa, health officials say 5:13 PM UTC · Updated ago Healthcare & Pharmaceuticalscategory More time and money needed to wipe out ...